Merck’s Patent Win Over Gilead Reversed Over False TestimonyKartikay Mehrotra and Pamela MacLean
Judge throws out $200 million jury verdict in hepatitis C case
Gilead’s Harvoni, Sovaldi drugs dominate market for treatment
To continue reading this article you must be a Bloomberg Professional Service Subscriber.
If you believe that you may have received this message in error please let us know.
You might like: